4 completed. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 2 |
Follow Mefenamic Acid: new trials by email Literature Review of Mefenamic Acid trials Research Report on Mefenamic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preemptive Analgesia for Primary Dysmenorrhoea preemptive mefenamic acid, mefenamic acid - Primary Dysmenorrhea | Phase 2 / Phase 3 | Completed | Hanan Nabil | 84 | 2017-08-01 | 2017-12-19 |
| DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis DLBS1442 100, Mefenamic acid, DLBS1442 200 - Endometrioma, Visual Analogue Pain Scale: Moderate or Severe Pain | Phase 2 / Phase 3 | Completed | Dexa Medica Group | 60 | 2015-10-01 | 2022-01-27 |
| Efficacy of Different Drugs to Control Post Root Canal Treatment Pain Paracetamol, Ibuprofen, Mefenamic Acid - Pain, Postoperative Pain | Phase 2 | Completed | University of Khartoum | 185 | 2012-08-01 | 2026-08-10 |
| Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea Meloxicam 7.5 mg, Meloxicam 15 mg, Mefenamic acid 500 mg - Dysmenorrhea | Phase 2 | Completed | Boehringer Ingelheim | 337 | 1998-01-01 | 2018-08-31 |
Pain (2) · Dysmenorrhea (1) · Endometriosis (1) · Pain, Postoperative (1)
Boehringer Ingelheim (1) · Dexa Medica Group (1) · Hanan Nabil (1) · University of Khartoum (1)
Egypt (1) · Indonesia (1) · Sudan (1)
Hanan Nabil, MD (1) · Kanadi Sumapraja, SpOG(K), MD (1) · Neamat Abubakr, BDS,MDSc,PhD (1)
PMID 10613619, PMID 12148679, PMID 15230906, PMID 17437870, PMID 18498882, PMID 27080115, PMID 9594474